Francisco Altamirano, Melissa Yuan, Sandra Hoyek, Daniel Hu, Muhammad Abidi, Celine Chaaya, Hanna De Bruyn, Anne Fulton, Iason S Mantagos, Carolyn Wu, Ryan Gise, Efren Gonzalez, Deborah K VanderVeen, Nimesh A Patel
{"title":"评估早产儿视网膜病变初始检查的效用:中等风险队列中FIRST-ROP算法的建议。","authors":"Francisco Altamirano, Melissa Yuan, Sandra Hoyek, Daniel Hu, Muhammad Abidi, Celine Chaaya, Hanna De Bruyn, Anne Fulton, Iason S Mantagos, Carolyn Wu, Ryan Gise, Efren Gonzalez, Deborah K VanderVeen, Nimesh A Patel","doi":"10.1016/j.ophtha.2025.01.004","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To assess the utility of the first or second examinations for retinopathy of prematurity (ROP) in a medium-risk cohort of infants and to propose an optimization to the current ROP screening guidelines.</p><p><strong>Design: </strong>Retrospective consecutive study.</p><p><strong>Subjects: </strong>Infants screened for ROP between January 2017 and August 2023 at three different tertiary-level care neonatal intensive care units.</p><p><strong>Methods: </strong>The analysis focused on patients who did not meet criteria for micro or nanoprematurity (those born at ≥27 weeks and weighing ≥800 grams).</p><p><strong>Main outcome measures: </strong>The primary outcomes included the rates of ROP and treatment-warranted ROP (TW-ROP), the presence of TW-ROP at the first or second inpatient examinations, the number of inpatient examinations performed before the first ROP diagnosis, and the overall number of inpatient examinations performed.</p><p><strong>Results: </strong>A total of 2,004 neonates were screened for ROP, of which 1,125 (56.1%) met the inclusion criteria. Of those patients, 237 (21.1%) had ROP. Eleven infants (1.0%) required treatment for active disease. The median postmenstrual age (PMA) at first ROP diagnosis was 35.3 weeks (IQR, 33.7-37 weeks; range, 30.3-46.7 weeks). The median PMA at stage 3 diagnosis was 39.3 weeks (IQR, 38.3-41.2 weeks; range, 35.1-44.4 weeks). The median PMA at first treatment was 39.6 weeks (IQR, 35.8-43.3 weeks; range, 35.3-49.6 weeks). The median number of inpatient examinations was 2.0 (IQR, 1-4 exams) for traditional screening, 1.0 (IQR, 1-3) after eliminating the first ROP inpatient examination, and 1.0 (IQR, 1-2) after eliminating the first and second ROP examinations (p<0.001). No patients were diagnosed with stage ≥3 nor met type 1 ROP treatment criteria at the first or second inpatient examination (100% sensitivity for TW-ROP). In this cohort, starting exams at 34 weeks PMA would be estimated to save 30.6% of the inpatient examinations.</p><p><strong>Conclusions: </strong>In infants not meeting criteria for micro and/or nanoprematurity, there was no type 1 ROP at either of the first two inpatient examinations. We propose an amendment algorithm (FIRST-ROP) in which ROP exams start at 34 weeks PMA for neonates born at ≥27 weeks gestational age and ≥800 grams.</p>","PeriodicalId":19533,"journal":{"name":"Ophthalmology","volume":" ","pages":""},"PeriodicalIF":13.1000,"publicationDate":"2025-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Evaluating the Utility of Initial Exams in Retinopathy of Prematurity: Proposal of FIRST-ROP Algorithm for a Medium-Risk Cohort.\",\"authors\":\"Francisco Altamirano, Melissa Yuan, Sandra Hoyek, Daniel Hu, Muhammad Abidi, Celine Chaaya, Hanna De Bruyn, Anne Fulton, Iason S Mantagos, Carolyn Wu, Ryan Gise, Efren Gonzalez, Deborah K VanderVeen, Nimesh A Patel\",\"doi\":\"10.1016/j.ophtha.2025.01.004\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>To assess the utility of the first or second examinations for retinopathy of prematurity (ROP) in a medium-risk cohort of infants and to propose an optimization to the current ROP screening guidelines.</p><p><strong>Design: </strong>Retrospective consecutive study.</p><p><strong>Subjects: </strong>Infants screened for ROP between January 2017 and August 2023 at three different tertiary-level care neonatal intensive care units.</p><p><strong>Methods: </strong>The analysis focused on patients who did not meet criteria for micro or nanoprematurity (those born at ≥27 weeks and weighing ≥800 grams).</p><p><strong>Main outcome measures: </strong>The primary outcomes included the rates of ROP and treatment-warranted ROP (TW-ROP), the presence of TW-ROP at the first or second inpatient examinations, the number of inpatient examinations performed before the first ROP diagnosis, and the overall number of inpatient examinations performed.</p><p><strong>Results: </strong>A total of 2,004 neonates were screened for ROP, of which 1,125 (56.1%) met the inclusion criteria. Of those patients, 237 (21.1%) had ROP. Eleven infants (1.0%) required treatment for active disease. The median postmenstrual age (PMA) at first ROP diagnosis was 35.3 weeks (IQR, 33.7-37 weeks; range, 30.3-46.7 weeks). The median PMA at stage 3 diagnosis was 39.3 weeks (IQR, 38.3-41.2 weeks; range, 35.1-44.4 weeks). The median PMA at first treatment was 39.6 weeks (IQR, 35.8-43.3 weeks; range, 35.3-49.6 weeks). The median number of inpatient examinations was 2.0 (IQR, 1-4 exams) for traditional screening, 1.0 (IQR, 1-3) after eliminating the first ROP inpatient examination, and 1.0 (IQR, 1-2) after eliminating the first and second ROP examinations (p<0.001). No patients were diagnosed with stage ≥3 nor met type 1 ROP treatment criteria at the first or second inpatient examination (100% sensitivity for TW-ROP). In this cohort, starting exams at 34 weeks PMA would be estimated to save 30.6% of the inpatient examinations.</p><p><strong>Conclusions: </strong>In infants not meeting criteria for micro and/or nanoprematurity, there was no type 1 ROP at either of the first two inpatient examinations. We propose an amendment algorithm (FIRST-ROP) in which ROP exams start at 34 weeks PMA for neonates born at ≥27 weeks gestational age and ≥800 grams.</p>\",\"PeriodicalId\":19533,\"journal\":{\"name\":\"Ophthalmology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":13.1000,\"publicationDate\":\"2025-01-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Ophthalmology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.ophtha.2025.01.004\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"OPHTHALMOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ophthalmology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ophtha.2025.01.004","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
Evaluating the Utility of Initial Exams in Retinopathy of Prematurity: Proposal of FIRST-ROP Algorithm for a Medium-Risk Cohort.
Purpose: To assess the utility of the first or second examinations for retinopathy of prematurity (ROP) in a medium-risk cohort of infants and to propose an optimization to the current ROP screening guidelines.
Design: Retrospective consecutive study.
Subjects: Infants screened for ROP between January 2017 and August 2023 at three different tertiary-level care neonatal intensive care units.
Methods: The analysis focused on patients who did not meet criteria for micro or nanoprematurity (those born at ≥27 weeks and weighing ≥800 grams).
Main outcome measures: The primary outcomes included the rates of ROP and treatment-warranted ROP (TW-ROP), the presence of TW-ROP at the first or second inpatient examinations, the number of inpatient examinations performed before the first ROP diagnosis, and the overall number of inpatient examinations performed.
Results: A total of 2,004 neonates were screened for ROP, of which 1,125 (56.1%) met the inclusion criteria. Of those patients, 237 (21.1%) had ROP. Eleven infants (1.0%) required treatment for active disease. The median postmenstrual age (PMA) at first ROP diagnosis was 35.3 weeks (IQR, 33.7-37 weeks; range, 30.3-46.7 weeks). The median PMA at stage 3 diagnosis was 39.3 weeks (IQR, 38.3-41.2 weeks; range, 35.1-44.4 weeks). The median PMA at first treatment was 39.6 weeks (IQR, 35.8-43.3 weeks; range, 35.3-49.6 weeks). The median number of inpatient examinations was 2.0 (IQR, 1-4 exams) for traditional screening, 1.0 (IQR, 1-3) after eliminating the first ROP inpatient examination, and 1.0 (IQR, 1-2) after eliminating the first and second ROP examinations (p<0.001). No patients were diagnosed with stage ≥3 nor met type 1 ROP treatment criteria at the first or second inpatient examination (100% sensitivity for TW-ROP). In this cohort, starting exams at 34 weeks PMA would be estimated to save 30.6% of the inpatient examinations.
Conclusions: In infants not meeting criteria for micro and/or nanoprematurity, there was no type 1 ROP at either of the first two inpatient examinations. We propose an amendment algorithm (FIRST-ROP) in which ROP exams start at 34 weeks PMA for neonates born at ≥27 weeks gestational age and ≥800 grams.
期刊介绍:
The journal Ophthalmology, from the American Academy of Ophthalmology, contributes to society by publishing research in clinical and basic science related to vision.It upholds excellence through unbiased peer-review, fostering innovation, promoting discovery, and encouraging lifelong learning.